STUDIES ON THERMOREVERSIVE MUCOADHESIVE OPHTHALMIC IN SITU GEL OF AZTHROMYCIN by Bhatia, Honey Bala et al.
Bhatia et al                                      Journal of Drug Delivery & Therapeutics; 2013, 3(5), 106-109    106 
© 2011, JDDT. All Rights Reserved                                                       ISSN: 2250-1177                                                      CODEN (USA): JDDTAO 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
STUDIES ON THERMOREVERSIVE MUCOADHESIVE OPHTHALMIC IN SITU GEL OF 
AZITHROMYCIN 
Bhatia Honey Bala
1
*, Sachan Ajay
2
, Bhandari Anil
3 
1
Algen Exports, 487/65, National Market, Peeragarhi, New Delhi, India 
2
Central Drugs Standard Control Organization, New Delhi, India
 
3
Faculty of Pharmaceutical Sciences, Jodhpur National University, Jodhpur-342001, Rajasthan, India 
*Corresponding Author, E-mail: algen.healthcare@gmail.com, hbhatia@algen.co.in 
 
 
 
 
 
 
 
INTRODUCTION 
Several approaches have been tried towards the 
development of stable sustained release in-situ ophthalmic 
gel so as to overcome problems associated with 
conventional ophthalmic dosage form. Conventional 
ophthalmic drops exhibit a short pre-corneal residence 
time and poor bioavailability due to rapid and extensive 
pre-corneal elimination of drugs by solution drainage, 
lachrymation, and non-productive absorption by 
conjunctiva. In addition to this, drugs that are hydrophobic 
or unstable at the pH of eye fluids cannot be formulated as 
eye drops. Because of limitations of bioavailability 
pertaining to ocular route, there are many potent drugs, 
which still need to be studied for their therapeutic potential 
by topical ocular route. Novel drug delivery systems such 
as in situ gels could prove effective approaches of 
exploring the potential of such drugs. In situ gel system is 
formulated as liquid preparation suitable to be instilled into 
eyes which upon exposure to the physiological 
environment changes to gel results in formation of in situ 
gel thus  increasing the precorneal residence time of the 
delivery system, and enhances the ocular bioavailability of 
the drug.
1-6 
Azithromycin, a macrolide antibiotic agent synthetically 
derived from erythromycin, binds to the 50S ribosomal 
subunit of bacteria and inhibits protein translation and 
bacterial growth.
7,8 
Laboratory studies of aqueous 
Azithromycin solutions have shown bactericidal capability 
against Staphylococcus aureus, Pseudomonas aeruginosa, 
and respiratory pathogens.
9.10 
In ophthalmology, oral 
administration of Azithromycin has been proven effective 
for the treatment of trachoma. The treatment of ocular 
surface infections with topical Azithromycin is desirable in 
medicine because systemic exposure to the drug is 
limited.
11
 Major topical formulation problems arise from 
the fact that Azithromycin is hydrophobic and sparingly 
soluble in water at neutral pH.
7
 Therefore, there is a need 
to design a novel drug delivery system, which could 
deliver the drug topically. In situ gels are viscous liquids 
that upon exposure to physiological conditions change into 
a gel or solid phase in the cul de sac upon its instillation 
into the eye. In situ gelation approach combines 
advantages of both solutions and gels, such as accuracy 
and ease of administration of the solution and prolonged 
precorneal retention of the gel. 
12,13
 
Depending on the method employed to cause sol to gel 
phase transition on the ocular surface, the following three 
types of systems have been recognized
13
:  
pH-triggered - The polymers used in this system 
are Pseudolatexes - Carbomer (carbopol), Cellulose acetate 
phthalate latex (CAP-latex).  
 Temperature-dependent - Poloxamers (Pluronic, 
Tetronics), Cellulose derivatives (MC, HPMC), 
Xyloglucan.  
 Ion-activated induced - Alginates, Gelrite® 
(Gellan gum)   
For the present work, in situ gels based on 
thermoreversible Poloxamer 407 polymer were developed. 
MATERIALS AND METHODS 
For the present work, in situ gels based on 
thermoreversible Poloxamer 407 polymer were developed. 
To develop such a temperature-sensitive gel, the amount 
required of Poloxamer is very large when it is used alone. 
Therefore, it is desirable to use other polymer materials 
along with Poloxamer. By doing this, not only can we 
reduce the amount of Poloxamer, but also can improve the 
adhesion of formulation materials to prolong the release of 
Azithromycin. Hence thermoreversible bioadhesive gels 
were prepared using poloxamer 407 and different other 
mucoadhesive polymers such as Sodium Carboxy Methyl 
cellulose (Na CMC), Hydroxy Propyl Methyl Cellulose 
(HPMC) K100Lvp, and Polyvinyl Pyrrolidone (PVP) K30. 
ABSTRACT 
In the present work, stability studies, microbiological study, ocular irritation studies and ocular permeation studies were 
performed on prepared thermoreversible gels of Azithromycin. Franz-diffusion cell consisting of a receptor cell and donor cell 
was used for trans-corneal permeation studies. Out of several developed Formulations, Formulation code A was selected on 
the basis of in vitro release studies, and was subjected to trans-corneal permeation studies through a goat's corneal membrane. 
The developed thermoreversible in situ gel was found to be stable, non-irritant, passing the sterility test, having antimicrobial 
activity and sustained drug release profile. 
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Gels were evaluated for physical parameters like 
appearance, gelation temperature, pH, spreadability, drug 
content and gel strength
14
. 
Preparation of in situ gel 
Thermoreversible mucoadhesive gels of Azithromycin 
were prepared by cold method as described by Schmolka 
et al
15
 using a mechanical stirrer. Accurately weighed 
quantities of poloxamer and bioadhesive polymers (Table 
1), bezalkonium chloride, were dissolved in phosphate 
buffer of pH 6.0. To these solutions, the required amount 
of Azithromycin was added under rapid stirring. The 
volume was adjusted with phosphate buffer to reach a final 
concentration of Azithromycin of 1.0% (w/v). The solution 
was mixed well and stored at 4°C for overnight which 
resulted into a clear solution. The developed formulations 
were filled in 5-ml amber glass vials, closed with gray 
butyl rubber closures and sealed with aluminum caps. The 
formulae for the drug formulations are given in Table 1.  
All gel formulations were evaluated for physical 
appearance, pH, content uniformity, viscosity, gelation 
temperature, gel strength, spreadability and invitro drug 
release.   
Based upon the result of in vitro drug release which 
showed that drug diffusion through the dialysis membrane 
occurred in the order NaCMC>PVP K30>HPMC 
K100Lvp, Gel formulation code A with 0.5% Sodium 
Carboxy Methyl Cellulose (NaCMC) was selected to carry 
out stability, microbiological, ocular irritation and 
permeation studies
14
. 
 
Table 1: Formulation Codes of thermoresponsive bioadhesive gels of Azithromycin 
Formula Code 
Ingredients A B C D E F G H I 
Azithromycin(g) 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Poloxamer 407(g) 75.0 75.0 75.0 75.0 75.0 75.0 75.0 75.0 75.0 
NaCMC(g) 2.5 5.0 7.5 - -  - - - 
HPMC 
K100Lvp(g) 
- - - 2.5 5.0 7.5 - - - 
PVPK30(g) - - - - - - 2.5 5.0 7.5 
Benzalkonium 
Chloride 
(0.01%w/v) 
(g) 
0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
Phosphate Buffer 
pH 6.0 q.s. 
500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 500ml 
 
Ocular Permeation Studies across goat’s corneal 
membrane 
Goat‟s cornea was used for the present investigation 
to study the permeation across the corneal membrane. 
Whole eyeballs of goat were procured from 
a slaughter house and carried to laboratory in cold 
condition in normal saline maintained at 4◦C.The cornea 
were carefully removed and washed with cold normal 
saline. The washed corneas were kept in cold freshly 
prepared solution of tear buffer of pH7.4.The study was 
carried out by using Franz-diffusion cell keeping the 
corneal side in continuous contact with formulation In the 
donor compartment. The formulation to be tested was 
added to the donor chamber with the help of a 
micropipette. The receptor compartment was filled with 
Simulated Tear Fluid (STF) of pH7.4 at 37◦C±0.5◦C. The 
receptor medium was stirred on a magnetic stirrer. 
The samples were withdrawn at different 
time intervals and analyzed for drug content. Receptor 
medium was replaced with an equal volume 
of STF (pH 7.4) at each time interval in order to maintain 
sinking conditions. The samples were appropriately diluted 
and analyzed. The percent drug released was plotted 
against time to get the release profile.  
Microbiological studies 
The microbiological studies were carried out to ascertain 
the biological activity of the optimized formulation Code 
A and compared with marketed eye drops against 
microorganism (Staphylococcus aureus) applying „cup 
plate method'. A layer of nutrient agar (20 mL) was seeded 
with 0.2 mL of test micro-organism and 7 μl of STF and 
allowed to solidify in the petriplate. Cups were made with 
the help of sterile borer at 4 mm diameter on the solidified 
agar layer. The formulations, 25 μl of each were poured 
into respective cups in an aseptic condition. These plates 
were kept in incubator for a period of 24 h and then 
observed for zone of inhibition. Marketed eye drops of 
Azithromycin were put in another petri plate for 
comparison. 
Ocular irritation study 
Ocular irritation study of the developed formulation was 
performed on hen‟s egg chorioallantoic membrane test 
which is a rapid, sensitive, and inexpensive test. Testing 
with an incubated egg is a borderline case between in vivo 
and in vitro systems and does not conflict with the ethical 
and legal obligations. The chorioallantoic membrane of the 
chick embryo is a complete tissue including veins, arteries, 
and capillaries and is technically very easy to study. It 
responds to injury with a complete inflammatory process, a 
process similar to that induced in the conjunctival tissue of 
the mammals. Developed formulation was tested by this 
method and the result was compared with those obtained 
using normal saline, which was used as control that is 
supposed to be practically non-irritant. A marketed 
formulation of Azithromycin 1% Eye drops was also used 
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in the ocular irritation studies in comparison with the 
developed gels. A means score of 0 was obtained for 
normal saline. The formulation was tested in gel forms A 
to I. Cumulative score for the gels A to I in gel form were 
0. These scores suggested the formulated gels were 
practically non-irritant. However, slightly higher but non-
significant cumulative score (0.9) was obtained in case of 
marketed eye drops of Azithromycin, which might be due 
to slightly acidic pH of the formulation (6.2). Since, a zero 
cumulative score was obtained for gels, it can be said that 
the formulated gels were non-irritating.  
Sterility testing 
Sterility testing was done as per IP 1996 by employing 
membrane filtration technique. It was carried out by 
incubating formulations for not less than 14 days at 30 to 
35◦C in the fluid thioglycolate medium to find the growth 
of anaerobic bacteria and at 20 to 25◦C in the soyabean 
casein digest medium to find the growth of aerobic 
bacteria and fungi in the formulation.  
Stability study  
The formulation code A was selected for the stability study 
which was conducted according to the International 
Conference on Harmonization guidelines (ICH). A 
sufficient quantity of gel solution in glass vials was kept in 
the oven maintained at temperature of 30 ± 2°C and 
relative humidity of 60 ± 5%. The samples were 
withdrawn at initial, one month, two months and three 
months‟ time intervals. The physical parameters of the gel 
were observed periodically by checking clarity, gel 
temperature, viscosity and in-vitro drug release profile. 
RESULT AND DISCUSSIONS 
Ocular irritation study 
The results of ocular irritation studies showed that the 
formulated gel was nonirritant without any ocular damage 
or visible abnormal clinical signs. Therefore the developed 
in situ gel can be safely instilled into the eye without any 
adverse effects. 
Sterility study 
The optimized formulation passed the test for sterility as 
there was no appearance of turbidity and hence no 
evidence of microbial growth when incubated for not less 
than 14 days a 30-35°C in case of fluid thioglycolate 
medium and at 20-25°C in the case of soyabean casein 
digest medium. 
Stability Study  
The stability study was carried out on the formulation code 
A at 30 ± 2°C and 60 ± 5% RH for three months. The 
formulations were clear and no significant changes were 
observed in gelation temperature, viscosity, in-vitro drug 
release profile as shown in Table 2.  
 
Table 2: Stability Profile of Formulation Code A 
Time interval 
(Months) 
Physical Appearance 
of the gel 
Gel temperature 
(°C) 
Viscosity (cP) at 
20 rpm and 37°C 
Cumulative % drug release 
At after 5 hours 
Initial Clear 35.6± 0.2 4900±0.5 90.12 
1 clear 35.7± 0.2 4910±0.5 90.13 
2 clear 35.6± 0.2 4907±0.5 91.17 
3 clear 35.5± 0.2 4920±0.5 90.14 
 
Antimicrobial Activity 
Antimicrobial activity studies showed that diameter of 
Zone of Inhibition (ZOI) with formulation code A were 
slightly bigger than that of marketed formulation of 
Azithromycin which proved that the prepared in situ gel 
inhibited the growth of Staphylococcus aureus at par with 
the marketed formulation. The higher ZOI values obtained 
for the developed gel in comparison to the marketed 
formulation solution could be attributed to the slow and 
prolonged diffusion of Azithromycin from polymeric gel 
due to its high viscosity  
Table 3: Antimicrobial activity of the in situ gels against 
Staphylococcus aureus in cup and plate technique 
In situ gel formulation Zone of Inhibition(mm) 
Formulation Code A 28±0.30 
 
 
Marketed Formulation of 
Azithromycin 
32±0.40 
 
Ex vivo corneal permeation studies 
Trans-corneal permeation studies were performed using 
isolated goat‟s cornea on Franz‐diffusion cell using STF 
(pH 7.4) at 37 ± 0.5 º C. The samples were withdrawn at 
regular intervals and analyzed for drug content. The 
percent drug released was plotted against time to get drug 
release profile. Table 4 shows the percent drug release and 
Fig. 1 shows the percent drug release. 
Table 4: Drug Release profile of Formulation code A on 
isolated goat‟s cornea 
Time (hrs) % Drug Release 
0 0.00 
1 41.00 
2 52.03 
3 65.03 
4 76.30 
5 90.09 
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Time (hrs) 
CONCLUSION 
The purpose of the present study was to improve the 
precorneal residence time and sustain the drug release by 
applying the in situ gelling system approach using 
Poloxamer in combination with NaCMC, HPMC K100Lvp 
and PVP K30. It was envisaged that this technique would 
prove successful for the drug Azithromycin improving its 
precorneal residence time and sustaining its release. 
Therefore, the developed in situ gels represent a viable 
alternative to conventional eye drops. The study showed 
that a thermoreversible polymer and mucoadhesive 
polymer can effectively be used to prolong residence time 
of the drug. 
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